Chemicals - Specialty
Compare Stocks
4 / 10Stock Comparison
APD vs EMN vs LIN vs LYB
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
APD vs EMN vs LIN vs LYB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $66.84B | $8.66B | $232.56B | $23.67B |
| Revenue (TTM) | $12.46B | $8.64B | $34.66B | $22.48B |
| Net Income (TTM) | $2.11B | $399M | $7.13B | $-774M |
| Gross Margin | 32.0% | 19.8% | 46.0% | -19.3% |
| Operating Margin | 18.4% | 9.4% | 28.8% | -0.9% |
| Forward P/E | 22.9x | 12.8x | 28.1x | 10.2x |
| Total Debt | $18.41B | $5.08B | $26.99B | $15.96B |
| Cash & Equiv. | $1.86B | $566M | $5.06B | $3.45B |
APD vs EMN vs LIN vs LYB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Air Products and Ch… (APD) | 100 | 124.2 | +24.2% |
| Eastman Chemical Co… (EMN) | 100 | 111.3 | +11.3% |
| Linde plc (LIN) | 100 | 248.0 | +148.0% |
| LyondellBasell Indu… (LYB) | 100 | 115.2 | +15.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: APD vs EMN vs LIN vs LYB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
APD plays a supporting role in this comparison — it may shine differently against other peers.
EMN lags the leaders in this set but could rank higher in a more targeted comparison.
LIN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 376.9% 10Y total return vs APD's 166.7%
- Lower volatility, beta 0.24, Low D/E 67.9%, current ratio 0.88x
- PEG 1.11 vs EMN's 4.00
LYB is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 2 yrs, beta 0.38, yield 7.5%
- Beta 0.38, yield 7.5%, current ratio 1.77x
- 7.5% yield, 2-year raise streak, vs APD's 2.4%
- +40.1% vs EMN's +3.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs LYB's -25.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.6% margin vs LYB's -3.4% | |
| Stability / Safety | Beta 0.24 vs EMN's 1.36, lower leverage | |
| Dividends | 7.5% yield, 2-year raise streak, vs APD's 2.4% | |
| Momentum (1Y) | +40.1% vs EMN's +3.9% | |
| Efficiency (ROA) | 8.3% ROA vs LYB's -3.0%, ROIC 11.3% vs -1.1% |
APD vs EMN vs LIN vs LYB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
APD vs EMN vs LIN vs LYB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 3 of 6 categories
EMN leads 1 • APD leads 0 • LYB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 4.0x EMN's $8.6B. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to LYB's -3.4%. On growth, APD holds the edge at +8.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $12.5B | $8.6B | $34.7B | $22.5B |
| EBITDAEarnings before interest/tax | $3.9B | $1.2B | $12.1B | $865M |
| Net IncomeAfter-tax profit | $2.1B | $399M | $7.1B | -$774M |
| Free Cash FlowCash after capex | $1.1B | $498M | $5.1B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +32.0% | +19.8% | +46.0% | -19.3% |
| Operating MarginEBIT ÷ Revenue | +18.4% | +9.4% | +28.8% | -0.9% |
| Net MarginNet income ÷ Revenue | +16.9% | +4.6% | +20.6% | -3.4% |
| FCF MarginFCF ÷ Revenue | +8.9% | +5.8% | +14.7% | +13.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.8% | -4.9% | +8.2% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +141.1% | -40.8% | +13.4% | -100.0% |
Valuation Metrics
EMN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 18.5x trailing earnings, EMN trades at a 46% valuation discount to LIN's 34.4x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.36x vs EMN's 5.75x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $66.8B | $8.7B | $232.6B | $23.7B |
| Enterprise ValueMkt cap + debt − cash | $83.4B | $13.2B | $254.5B | $36.2B |
| Trailing P/EPrice ÷ TTM EPS | -169.61x | 18.47x | 34.40x | -31.27x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.86x | 12.85x | 28.12x | 10.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 5.75x | 1.36x | — |
| EV / EBITDAEnterprise value multiple | 121.35x | 9.12x | 20.04x | 34.04x |
| Price / SalesMarket cap ÷ Revenue | 5.55x | 0.99x | 6.84x | 0.79x |
| Price / BookPrice ÷ Book value/share | 3.86x | 1.45x | 5.92x | 2.32x |
| Price / FCFMarket cap ÷ FCF | — | 20.43x | 45.70x | 61.65x |
Profitability & Efficiency
LIN leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-7 for LYB. LIN carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to LYB's 1.56x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs APD's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.9% | +6.7% | +17.8% | -7.2% |
| ROA (TTM)Return on assets | +5.1% | +2.6% | +8.3% | -3.0% |
| ROICReturn on invested capital | -2.0% | +6.7% | +11.3% | -1.1% |
| ROCEReturn on capital employed | -2.4% | +7.5% | +13.0% | -1.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 6 | 3 |
| Debt / EquityFinancial leverage | 1.06x | 0.84x | 0.68x | 1.56x |
| Net DebtTotal debt minus cash | $16.6B | $4.5B | $21.9B | $12.5B |
| Cash & Equiv.Liquid assets | $1.9B | $566M | $5.1B | $3.4B |
| Total DebtShort + long-term debt | $18.4B | $5.1B | $27.0B | $16.0B |
| Interest CoverageEBIT ÷ Interest expense | 12.00x | 2.22x | 34.52x | -1.42x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $17,813 today (with dividends reinvested), compared to $7,381 for EMN. Over the past 12 months, LYB leads with a +40.1% total return vs EMN's +3.9%. The 3-year compound annual growth rate (CAGR) favors LIN at 12.4% vs LYB's -1.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.3% | +19.0% | +17.3% | +67.1% |
| 1-Year ReturnPast 12 months | +14.9% | +3.9% | +13.6% | +40.1% |
| 3-Year ReturnCumulative with dividends | +8.8% | +6.0% | +41.9% | -3.4% |
| 5-Year ReturnCumulative with dividends | +13.8% | -26.2% | +78.1% | -9.6% |
| 10-Year ReturnCumulative with dividends | +166.7% | +36.1% | +376.9% | +49.4% |
| CAGR (3Y)Annualised 3-year return | +2.8% | +1.9% | +12.4% | -1.1% |
Risk & Volatility
Evenly matched — APD and LIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than EMN's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APD currently trades 97.7% from its 52-week high vs LYB's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 1.36x | 0.24x | 0.38x |
| 52-Week HighHighest price in past year | $307.29 | $84.18 | $521.28 | $83.94 |
| 52-Week LowLowest price in past year | $229.11 | $56.11 | $387.78 | $41.58 |
| % of 52W HighCurrent price vs 52-week peak | +97.7% | +90.0% | +96.3% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 61.2 | 62.8 | 50.6 | 60.4 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 1.5M | 2.3M | 8.1M |
Analyst Outlook
Evenly matched — APD and LYB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: APD as "Buy", EMN as "Buy", LIN as "Buy", LYB as "Hold". Consensus price targets imply 7.5% upside for LIN (target: $540) vs 0.2% for LYB (target: $74). For income investors, LYB offers the higher dividend yield at 7.46% vs LIN's 1.20%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $312.78 | $77.29 | $539.71 | $73.60 |
| # AnalystsCovering analysts | 42 | 35 | 28 | 39 |
| Dividend YieldAnnual dividend ÷ price | +2.4% | +4.4% | +1.2% | +7.5% |
| Dividend StreakConsecutive years of raises | 29 | 12 | 6 | 2 |
| Dividend / ShareAnnual DPS | $7.11 | $3.30 | $6.00 | $5.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +2.0% | +0.8% |
LIN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMN leads in 1 (Valuation Metrics). 2 tied.
APD vs EMN vs LIN vs LYB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is APD or EMN or LIN or LYB a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus -25. 2% for LyondellBasell Industries N. V. (LYB). Eastman Chemical Company (EMN) offers the better valuation at 18. 5x trailing P/E (12. 8x forward), making it the more compelling value choice. Analysts rate Air Products and Chemicals, Inc. (APD) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — APD or EMN or LIN or LYB?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
5x versus Linde plc at 34. 4x. On forward P/E, LyondellBasell Industries N. V. is actually cheaper at 10. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 11x versus Eastman Chemical Company's 4. 00x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — APD or EMN or LIN or LYB?
Over the past 5 years, Linde plc (LIN) delivered a total return of +78.
1%, compared to -26. 2% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: LIN returned +376. 9% versus EMN's +36. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — APD or EMN or LIN or LYB?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
24β versus Eastman Chemical Company's 1. 36β — meaning EMN is approximately 465% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 156% for LyondellBasell Industries N. V. — giving it more financial flexibility in a downturn.
05Which is growing faster — APD or EMN or LIN or LYB?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus -25. 2% for LyondellBasell Industries N. V. (LYB). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -156. 6% for LyondellBasell Industries N. V.. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — APD or EMN or LIN or LYB?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -3. 3% for Air Products and Chemicals, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -7. 3% for APD. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is APD or EMN or LIN or LYB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 11x versus Eastman Chemical Company's 4. 00x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, LyondellBasell Industries N. V. (LYB) trades at 10. 2x forward P/E versus 28. 1x for Linde plc — 17. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 7. 5% to $539. 71.
08Which pays a better dividend — APD or EMN or LIN or LYB?
All stocks in this comparison pay dividends.
LyondellBasell Industries N. V. (LYB) offers the highest yield at 7. 5%, versus 1. 2% for Linde plc (LIN).
09Is APD or EMN or LIN or LYB better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
24), 1. 2% yield, +376. 9% 10Y return). Both have compounded well over 10 years (LIN: +376. 9%, EMN: +36. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between APD and EMN and LIN and LYB?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: APD is a mid-cap quality compounder stock; EMN is a small-cap income-oriented stock; LIN is a large-cap quality compounder stock; LYB is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.